INFLAMMATION AND IMMUNOPHARMACOLOGY
Endocannabinoids Induce Ileitis in Rats via the Capsaicin Receptor (VR1)
Douglas C. Mcvey,
Patricia C. Schmid,
Harald H. O. Schmid, and
Steven R. Vigna
Departments of Cell Biology and Medicine, Duke University Medical Center,
Veterans Affairs Medical Center, Durham, North Carolina (D.C.M, S.R.V.); and
the Hormel Institute, University of Minnesota, Austin, Minnesota (P.C.S,
H.H.O.S.)
Intraluminal administration of the endocannabinoids
N-arachidonoyl-ethanolamine (anandamide) and 2-arachidonoylglycerol
(2-AG) causes inflammation similar to that caused by Clostridium
difficile toxin A in the rat ileum. The effects of anandamide and 2-AG
were significantly inhibited by pretreatment with the specific capsaicin
receptor (vanilloid receptor subtype 1; VR1) antagonist capsazepine.
Pretreatment with the CB1 and CB2 cannabinoid receptor antagonists
N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide
(SR141716) and
N-[1S)-endo-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide
(SR144528) did not affect the responses to anandamide. It has previously been
shown that intraluminal toxin A stimulates substance P (SP) release from
primary sensory neurons and that pretreatment with SP receptor [neurokinin
(NK)-1 receptor] antagonists inhibits the inflammatory effects of toxin A.
Anandamide stimulated SP release and this was blocked by capsazepine
pretreatment. Also, pretreatment with the specific NK-1 receptor antagonist
(2S,3S)-3-([3,5-bis[trifluoromethyl)phenyl]methoxy)-2-phenylpiperidine
(L-733,060) significantly inhibited the inflammatory effects of both toxin A
and anandamide. Toxin A increased tissue concentrations of anandamide and 2-AG
in the ileum, and these effects were enhanced after pretreatment with
inhibitors of fatty acid amide hydrolase, a major endocannabinoid-degrading
enzyme. The toxin A-stimulated release of anandamide but not 2-AG was
selective over their congeners. These results demonstrate that the
endocannabinoids anandamide and 2-AG stimulate intestinal primary sensory
neurons via the capsaicin VR1 receptor to release SP, resulting in enteritis,
and that endocannabinoids may mediate the inflammatory effects of toxin A.
Received August 4, 2002;
accepted October 3, 2002.
Address correspondence to: Steven R. Vigna, Department of Cell Biology,
Box 3709, Duke University Medical Center, Durham, NC 27710. E-mail:
srv{at}duke.edu
This article has been cited by other articles:

|
 |

|
 |
 
L. Cheng, S. de la Monte, J. Ma, J. Hong, M. Tong, W. Cao, J. Behar, P. Biancani, and K. M. Harnett
HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa
Am J Physiol Gastrointest Liver Physiol,
July 1, 2009;
297(1):
G135 - G143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Lin, R.-L. Lin, M.-Y. Bien, C.-Y. Ho, and Y. R. Kou
Sensitization of capsaicin-sensitive lung vagal afferents by anandamide in rats: role of transient receptor potential vanilloid 1 receptors
J Appl Physiol,
April 1, 2009;
106(4):
1142 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, H. Wang, W. Ning, M. G. Backlund, S. K. Dey, and R. N. DuBois
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Cancer Res.,
August 1, 2008;
68(15):
6468 - 6476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A A Izzo and M Camilleri
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Gut,
August 1, 2008;
57(8):
1140 - 1155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Di Marzo and A A Izzo
Endocannabinoid overactivity and intestinal inflammation.
Gut,
October 1, 2006;
55(10):
1373 - 1376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Guagnini, M Valenti, S Mukenge, I Matias, A Bianchetti, S Di Palo, G Ferla, V Di Marzo, and T Croci
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P
Gut,
July 1, 2006;
55(7):
946 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Fujino, S G de la Fuente, Y Takami, T Takahashi, and C R Mantyh
Attenuation of acid induced oesophagitis in VR-1 deficient mice
Gut,
January 1, 2006;
55(1):
34 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dinis, A. Charrua, A. Avelino, M. Yaqoob, S. Bevan, I. Nagy, and F. Cruz
Anandamide-Evoked Activation of Vanilloid Receptor 1 Contributes to the Development of Bladder Hyperreflexia and Nociceptive Transmission to Spinal Dorsal Horn Neurons in Cystitis
J. Neurosci.,
December 15, 2004;
24(50):
11253 - 11263.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.